Back to Search Start Over

Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.

Authors :
Garelja ML
Au M
Brimble MA
Gingell JJ
Hendrikse ER
Lovell A
Prodan N
Sexton PM
Siow A
Walker CS
Watkins HA
Williams GM
Wootten D
Yang SH
Harris PWR
Hay DL
Source :
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2020 Feb 26; Vol. 3 (2), pp. 246-262. Date of Electronic Publication: 2020 Feb 26 (Print Publication: 2020).
Publication Year :
2020

Abstract

Adrenomedullin (AM) is a 52 amino acid peptide that plays a regulatory role in the vasculature. Receptors for AM comprise the class B G protein-coupled receptor, the calcitonin-like receptor (CLR), in complex with one of three receptor activity-modifying proteins (RAMPs). The C-terminus of AM is involved in binding to the extracellular domain of the receptor, while the N-terminus is proposed to interact with the juxtamembranous portion of the receptor to activate signaling. There is currently limited information on the molecular determinants involved in AM signaling, thus we set out to define the importance of the AM N-terminus through five signaling pathways (cAMP production, ERK phosphorylation, CREB phosphorylation, Akt phosphorylation, and IP <subscript>1</subscript> production). We characterized the three CLR:RAMP complexes through the five pathways, finding that each had a distinct repertoire of intracellular signaling pathways that it is able to regulate. We then performed an alanine scan of AM from residues 15-31 and found that most residues could be substituted with only small effects on signaling, and that most substitutions affected signaling through all receptors and pathways in a similar manner. We identify F18, T20, L26, and I30 as being critical for AM function, while also identifying an analogue (AM <subscript>15-52</subscript> G19A) which has unique signaling properties relative to the unmodified AM. We interpret our findings in the context of new structural information, highlighting the complementary nature of structural biology and functional assays.<br />Competing Interests: The authors declare no competing financial interest.<br /> (Copyright © 2020 American Chemical Society.)

Details

Language :
English
ISSN :
2575-9108
Volume :
3
Issue :
2
Database :
MEDLINE
Journal :
ACS pharmacology & translational science
Publication Type :
Academic Journal
Accession number :
32296766
Full Text :
https://doi.org/10.1021/acsptsci.9b00083